GEIST:UPC Searchengine

ORD_28687/2025

QIAGEN Sciences, LLC v. bioMérieux S.A., bioMérieux Deutschland GmbH

Datum
2025-07-15
Kammer
Düsseldorf (DE) Local Division
Verfahrensart
Application RoP262A
Sprache
EN

Metadaten

Fall-IDORD_28687-2025-dc5a417c4a8d
Aktenzeichen
RegisterzeichenORD_28687/2025
EntscheidungsreferenzORD_28687/2025
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 11

1 Düsseldorf Local Division UPC_CFI_181/2025 Procedural Order of the Court of First Instance of the Unified Patent Court issued on 15 July 2025 concerning EP 2 726 883 CLAIMANT: QIAGEN Sciences, LL C, represented by its President and Chief Executive Officer Thierry Bernard, its Treasurer and CFO Roland Sackers, its Senior Vice President, Head of Global Operation Antonio Santos, and its Secretary Tim Grabham, 19300 Germantown Rd, Germantown, MD 20874, USA represented by: Attorney-at-law Dr Clemens Plassmann , Attorney -at-law Dr Markus Kuczera, Att orney-at-law Chia C. Chuong and all lawyers of Hogan Lovells International LLP who are authorised to act as representatives before the UPC, Dreischeibenhaus 1, 40211 Düsseldorf, Germany with support by: Patent Attorney Carla Roth, Dipl.-Biologin  ...